BRIEF-Regeneron and Sanofi announce Kevzara license application resubmission for review by FDA
April 28, 2017 at 02:13 AM EDT
* Regeneron and Sanofi announce Kevzara® (sarilumab) Biologics License Application resubmission accepted for review by U.S. FDA
